Wysa receives USFDA approval for AI led device for mental health – ET HealthWorld
Bangalore: Vaisa, n Artificial intelligence (AI) -based Platform for Behavioral Health, has announced that United States Food and Drug Administration (The FDA) Has successfully designated a device for its AI-based digital mental health communication agent with a diagnosis of chronic musculoskeletal pain, depression and anxiety for patients 18 years and older. The device delivers Cognitive … Read more
